Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Oct;4(5):535–540. doi: 10.1111/j.1365-2125.1977.tb00782.x

Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain.

P L Morselli, A Baruzzi, M Gerna, L Bossi, M Porta
PMCID: PMC1429158  PMID: 911603

Abstract

1 Carbamazepine (CBZ) brain and plasma concentrations were measured in twenty-one patients undergoing brain surgery for tumour removal. The drug was administered prophylactically at doses ranging from 6.9 to 14.8 mg/kg for 4-5 days before the intervention. 2 In seventeen cases where sample were collected 10-14 h after dosing, CBZ brain levels ranged from 2.2-14.5 microgram/g. A significant linear relationship (p less than 0.01) was observed between brain and plasma concentrations with a brain/plasma ratio of 1.1 +/- 0.1. 3 Carbamazepine 10,11-epoxide (CBZ-Epox), present in all samples, could be quantified in three brain specimens. Its brain concentrations ranged from 1.5-2.7 microgram/g with a brain/plasma ratio of 1.1-1.2. 4 Parieto-occipital areas tended to show higher CBZ concentrations while lower values were found in temporal regions. Very low CBZ levels were found in two gliomas while in meningiomas CBZ levels were similar to those observed in normal tissue. 5 The data, showing a linear relationship between brain and plasma concentrations of both CBZ and its epoxide, give additional significance to the plasma level monitoring of antiepileptic drugs.

Full text

PDF
535

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Celesia G. G., Booker H. E., Sato S. Brain and serum concentrations of diazepam in experimental epilepsy. Epilepsia. 1974 Sep;15(3):417–425. doi: 10.1111/j.1528-1157.1974.tb04017.x. [DOI] [PubMed] [Google Scholar]
  2. Cereghino J. J., Brock J. T., Van Meter J. C., Penry J. K., Smith L. D., White B. G. Carbamazepine for epilepsy. A controlled prospective evaluation. Neurology. 1974 May;24(5):401–410. doi: 10.1212/wnl.24.5.401. [DOI] [PubMed] [Google Scholar]
  3. Dalby M. A. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy. Epilepsia. 1971 Dec;12(4):325–334. doi: 10.1111/j.1528-1157.1971.tb04380.x. [DOI] [PubMed] [Google Scholar]
  4. Frigerio A., Morselli P. L. Carbamazepine: biotransformation. Adv Neurol. 1975;11:295–308. [PubMed] [Google Scholar]
  5. Gaches J., Supino V. Etude des séquelles épileptiques dans 28 cas de méningiomes opérés et suivis plus de dix ans. Neurochirurgie. 1970 Nov;16(6):489–512. [PubMed] [Google Scholar]
  6. Houghton G. W., Richens A., Toseland P. A., Davidson S., Falconer Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients. Eur J Clin Pharmacol. 1975 Oct 10;9(1):73–78. doi: 10.1007/BF00613432. [DOI] [PubMed] [Google Scholar]
  7. Kutt H., Louis S., McDowell F. Intravenous diphenylhydantoin in experimental seizures. I. Correlation of dose, blood, and tissue level in cats. Arch Neurol. 1968 May;18(5):465–471. doi: 10.1001/archneur.1968.00470350023001. [DOI] [PubMed] [Google Scholar]
  8. Levy R. H., Lockard J. S., Green J. R., Friel P., Martis L. Pharmacokinetics of carbamazepine in monkeys following intravenous and oral administration. J Pharm Sci. 1975 Feb;64(2):302–307. doi: 10.1002/jps.2600640224. [DOI] [PubMed] [Google Scholar]
  9. Levy R. H., Pitlick W. H., Troupin A. S., Green J. R., Neal J. M. Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther. 1975 Jun;17(6):657–668. doi: 10.1002/cpt1975176657. [DOI] [PubMed] [Google Scholar]
  10. Monaco F., Riccio A., Benna P., Covacich A., Durelli L., Fantini M., Furlan P. M., Gilli M., Mutani R., Troni W. Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology. 1976 Oct;26(10):936–973. doi: 10.1212/wnl.26.10.936. [DOI] [PubMed] [Google Scholar]
  11. Morselli P. L. Carbamazepine: absorption, distribution, and excretion. Adv Neurol. 1975;11:279–293. [PubMed] [Google Scholar]
  12. Morselli P. L., Frigerio A. Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev. 1975;4(1):97–113. doi: 10.3109/03602537508993750. [DOI] [PubMed] [Google Scholar]
  13. Morselli P. L., Gerna M., Garattini S. Carbamazepine plasma and tissue levels in the rat. Biochem Pharmacol. 1971 Aug;20(8):2043–2047. doi: 10.1016/0006-2952(71)90404-7. [DOI] [PubMed] [Google Scholar]
  14. Morselli P. L., Monaco F., Gerna M., Recchia M., Riccio A. Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. Epilepsia. 1975 Dec;16(5):759–764. doi: 10.1111/j.1528-1157.1975.tb04762.x. [DOI] [PubMed] [Google Scholar]
  15. NORTHCROFT G. B., WYKE B. D. Seizures following surgical treatment of intracranial abscesses; a clinical and electroencephalographic study. J Neurosurg. 1957 May;14(3):249–263. doi: 10.3171/jns.1957.14.3.0249. [DOI] [PubMed] [Google Scholar]
  16. Peserico L., Nori A., Ravenna C. L'epilessia postoperatoria nei meningiomi endocranici. Acta Neurochir (Wien) 1965;13(2):196–211. doi: 10.1007/BF02074538. [DOI] [PubMed] [Google Scholar]
  17. Rapport R. L., 2nd, Penry J. K. A survey of attitudes toward the pharmacological prophylaxis of posttraumatic epilepsy. J Neurosurg. 1973 Feb;38(2):159–166. doi: 10.3171/jns.1973.38.2.0159. [DOI] [PubMed] [Google Scholar]
  18. Rizzo M., Morselli P. L., Garattini S. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Biochem Pharmacol. 1972 Feb 15;21(4):449–454. doi: 10.1016/0006-2952(72)90317-6. [DOI] [PubMed] [Google Scholar]
  19. Rodin E. A., Rim C. S., Rennick P. M. The effects of carbamazepine on patients with psychomotor epilepsy: results of a double-blind study. Epilepsia. 1974 Dec;15(4):547–561. doi: 10.1111/j.1528-1157.1974.tb04028.x. [DOI] [PubMed] [Google Scholar]
  20. TERZIAN H. Le epilessie dopo intervento neurochirurgico. Rass Neurol Veg. 1954 Dec;10(5-6):646–656. [PubMed] [Google Scholar]
  21. Troupin A. S., Green J. R., Levy R. H. Carbamazepine as an anticonvulsant: a pilot study. Neurology. 1974 Sep;24(9):863–869. doi: 10.1212/wnl.24.9.863. [DOI] [PubMed] [Google Scholar]
  22. Vajda F., Williams F. M., Davidson S., Falconer M. A., Breckenridge A. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther. 1974 Jun;15(6):597–603. doi: 10.1002/cpt1974156597. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES